Omeros reported $4.93M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 327K 63K
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
Alnylam Pharmaceuticals ALNY:US $ 42.61M 247K
Biomarin Pharmaceutical BMRN:US $ 3.86M 0.05M
Cytokinetics CYTK:US $ 2.81M 0.06M
Dynavax Technologies DVAX:US $ 1.68M 0M
Gilead Sciences GILD:US $ 242M 4M
Insmed INSM:US $ 3.36M 66K
Intercept Pharmaceuticals ICPT:US $ 6.67M 0M
Knight Therapeutics Inc GUD:CN C$ 1.72M 606K
Omeros OMER:US $ 4.93M 14K
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Pfizer PFE:US $ 293M 29M
Regulus Therapeutics RGLS:US $ 0.16M 0.01M
Sarepta Therapeutics SRPT:US $ 16.03M 0.23M
United Therapeutics UTHR:US $ 6.2M 1.5M
Vertex Pharmaceuticals VRTX:US $ 14.6M 0.3M
Xoma XOMA:US $ 0 0